Tag: Bharat Biotech

COVAXIN Creator Dr. Krishna Ella Wins Prestigious Johns Hopkins Award

May 24, 2024: Dr. Krishna Ella, Co-founder and Executive Chairman of Bharat Biotech, has been awarded the prestigious

Covaxin: Facts vs. Fiction – Separating Truth from Misinformation

May 18, 2024: Covaxin, an inactivated virus vaccine developed by Bharat Biotech in India, has played a significant

Covaxin BHU Study: BB Points Flaws in Data Points, Backs Strong Safety Track Record

May 16, 2024: A recent study in SpringerLink examining Covaxin's long-term effects offers debatable findings. While the research

COVAXIN Safety Assured: Bharat Biotech Puts Safety First

May 2, 2024: In the interest of public health, Bharat Biotech reaffirmed the safety of India's COVAXIN®️, developed

Bharat Biotech and Bilthoven Biologicals Collaborate to Produce and Supply Oral Polio Vaccines

Bharat Biotech, a global leader in vaccine and biotherapeutic innovation, also the largest manufacturer of oral polio vaccines,

Bharat Biotech and University of Sydney Sign MoU to Advance Academic and Vaccine Research Collaboration

Hyderabad, India, and Sydney, Australia – 28th November 2023 – Bharat Biotech International Limited, a world leading vaccines

Bharat Biotech Nasal Vaccine as Covid Booster Dose, First in Hospitals: Govt

Indians' will soon have access to Bharat Biotech's covid-19 nasal vaccine "iNCOVACC" . Health Minister Dr Mansukh Mandaviya

iNCOVACC Fast Facts: World’s first Intranasal vaccine approved by India

Bharat Biotech iNCOVACC®️ (BBV154), has received approval from the Central Drugs Standard Control Organisation (CDSCO) under Restricted Use

Bharat Biotech firmly condemns baseless reports on COVAXIN Development

Bharat Biotech today strongly condemned fallacious and misleading information report recently by a foreign media. The company in

Nigeria to avert 50,000 child deaths annually with ROTAVAC vaccine

ROTAVAC®, the Bharat Biotech rotavirus vaccine has been introduced by Nigeria to immunize its children from the life-threatening

New SARS-CoV-2 vaccine to be developed by Bharat Biotech and its partners to prevent cross-reactivity

A new SARS-Cov-2 vaccine that prevents cross-reactivity development is in the offing. This is being carried out by

Bharat Biotech consortium project for new variant proof Covid-19 Vaccine Gets CEPI Funding

CEPI will provide funding of up to US$19.3 million to support the development of a ‘variant-proof’ SARS-CoV-2 vaccine